1. Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan
   Ping-Chih Hsu et al, 2023, Targeted Oncology CrossRef
2. MicroRNA‐140‐3p inhibits proliferation and promotes apoptosis in non‐small cell lung cancer by targeting MDIG
   Miaomiao Yu et al, 2024, Environmental Toxicology CrossRef
3. Advances in lymphatic metastasis of non-small cell lung cancer
   Xiaofei Zhang et al, 2024, Cell Communication and Signaling CrossRef
4. LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs
   Milad Shirvaliloo, 2023, Epigenomics CrossRef
5. Sequential treatment in advanced epidermal growth factor receptor-mutated lung adenocarcinoma patients receiving first-line bevacizumab combined with 1st/2nd-generation EGFR-tyrosine kinase inhibitors
   Ping-Chih Hsu et al, 2023, Frontiers in Oncology CrossRef
6. Expression analysis of MINA53: correlation with aberrantly expressed mRNAs and pathological features in non-small lung cancer
   Veronika Petkova et al, 2021, Biotechnology & Biotechnological Equipment CrossRef
7. MDIG, a 2‑oxoglutarate‑dependent oxygenase, acts as an oncogene and predicts the prognosis of multiple types of cancer
   Feng Geng et al, 2022, International Journal of Oncology CrossRef